• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可注射丝素蛋白水凝胶的生物降解可防止心肌梗死后左心室重构的恶化。

Biodegradation of injectable silk fibroin hydrogel prevents negative left ventricular remodeling after myocardial infarction.

机构信息

Department of Biomedical Engineering, National Cerebral and Cardiovascular Center (NCVC) Research Institute, 6-1 Kishibeshinmachi, Suita, Osaka 564-8565, Japan.

出版信息

Biomater Sci. 2019 Sep 24;7(10):4153-4165. doi: 10.1039/c9bm00556k.

DOI:10.1039/c9bm00556k
PMID:31368458
Abstract

In the present study, we investigated the optimal material properties of a tunable hydrogel for the treatment of myocardial infarction (MI) along with the therapeutic mechanism. We developed silk fibroin (SF) hydrogels with the same physical properties (e.g., stiffness) but different biodegradation rates via a peptide modification and evaluated the effect of hydrogel biodegradation on the prevention of negative left ventricular (LV) remodeling in a rat model of MI. LV enlargement was attenuated to a greater extent by injection of a slowly degrading unmodified SF hydrogel as compared to a rapidly degrading peptide-modified SF (SF + Pep) hydrogel for up to 12 weeks post-injection. This could not be explained by the mechanical stabilization of the LV wall by the injectant since the SF and SF + Pep hydrogels degraded completely within 4 weeks and the two groups showed no difference in LV wall thickness at 12 weeks. The SF group had dense randomly aligned collagen fibers whereas the SF + Pep group had sparse fibers surrounding the LV. These results suggest that randomly aligned fibrous tissues formed during/after biodegradation of a slowly degrading SF hydrogel may be more resistant to LV pressure and thus prevent LV enlargement.

摘要

在本研究中,我们研究了一种可调谐水凝胶的最佳材料特性,用于治疗心肌梗死(MI)以及治疗机制。我们通过肽修饰开发了具有相同物理性质(例如,硬度)但降解率不同的丝素蛋白(SF)水凝胶,并评估了水凝胶降解对预防 MI 大鼠模型中左心室(LV)重构的负面影响。与快速降解的肽修饰 SF(SF + Pep)水凝胶相比,注射缓慢降解的未修饰 SF 水凝胶在注射后长达 12 周时,LV 扩张程度得到了更大程度的抑制。这不能用注入物对 LV 壁的机械稳定来解释,因为 SF 和 SF + Pep 水凝胶在 4 周内完全降解,两组在 12 周时 LV 壁厚度没有差异。SF 组有密集的随机排列的胶原纤维,而 SF + Pep 组则有稀疏的纤维环绕 LV。这些结果表明,在缓慢降解的 SF 水凝胶的生物降解过程中/之后形成的随机排列的纤维组织可能对 LV 压力更具抵抗力,从而防止 LV 扩张。

相似文献

1
Biodegradation of injectable silk fibroin hydrogel prevents negative left ventricular remodeling after myocardial infarction.可注射丝素蛋白水凝胶的生物降解可防止心肌梗死后左心室重构的恶化。
Biomater Sci. 2019 Sep 24;7(10):4153-4165. doi: 10.1039/c9bm00556k.
2
Laccase-mediated construction of flexible double-network hydrogels based on silk fibroin and tyramine-modified hyaluronic acid.基于丝素蛋白和酪胺改性透明质酸的漆酶介导构建的柔性双网络水凝胶。
Int J Biol Macromol. 2020 Oct 1;160:795-805. doi: 10.1016/j.ijbiomac.2020.05.258. Epub 2020 Jun 1.
3
Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.壳聚糖/丝素蛋白改性纳米纤维贴片联合间充质干细胞预防大鼠心肌梗死后心脏重构。
Acta Biomater. 2018 Oct 15;80:154-168. doi: 10.1016/j.actbio.2018.09.013. Epub 2018 Sep 13.
4
In Situ Forming Injectable Silk Fibroin Hydrogel Promotes Skin Regeneration in Full Thickness Burn Wounds.原位形成可注射丝素蛋白水凝胶促进全厚度烧伤创面皮肤再生。
Adv Healthc Mater. 2018 Dec;7(24):e1801092. doi: 10.1002/adhm.201801092. Epub 2018 Oct 31.
5
Rheological and ion-conductive properties of injectable and self-healing hydrogels based on xanthan gum and silk fibroin.基于黄原胶和丝素蛋白的可注射和自修复水凝胶的流变学和离子传导性能。
Int J Biol Macromol. 2020 Feb 1;144:473-482. doi: 10.1016/j.ijbiomac.2019.12.132. Epub 2019 Dec 17.
6
Processing, mechanical properties and bio-applications of silk fibroin-based high-strength hydrogels.基于丝素蛋白的高强度水凝胶的处理、力学性能及生物应用。
Acta Biomater. 2021 Apr 15;125:57-71. doi: 10.1016/j.actbio.2021.02.018. Epub 2021 Feb 16.
7
Chitosan hydrogels significantly limit left ventricular infarction and remodeling and preserve myocardial contractility.壳聚糖水凝胶可显著限制左心室梗死和重塑,并维持心肌收缩力。
J Surg Res. 2016 Apr;201(2):490-7. doi: 10.1016/j.jss.2015.11.012. Epub 2015 Nov 19.
8
Cardiac repair using chitosan-hyaluronan/silk fibroin patches in a rat heart model with myocardial infarction.壳聚糖-透明质酸/丝素蛋白贴片在心肌梗死后大鼠心脏模型中的心脏修复作用。
Carbohydr Polym. 2013 Jan 30;92(1):591-7. doi: 10.1016/j.carbpol.2012.09.012. Epub 2012 Sep 16.
9
Initial immune response to a FRET-based MMP sensor-immobilized silk fibroin hydrogel in vivo.体内基于荧光共振能量转移(FRET)的 MMP 传感器固定丝素水凝胶的初始免疫反应。
Acta Biomater. 2021 Aug;130:199-210. doi: 10.1016/j.actbio.2021.05.030. Epub 2021 Jun 1.
10
Electromechanical response of silk fibroin hydrogel and conductive polycarbazole/silk fibroin hydrogel composites as actuator material.丝素蛋白水凝胶及导电聚咔唑/丝素蛋白水凝胶复合材料作为致动器材料的机电响应
Mater Sci Eng C Mater Biol Appl. 2015 Nov 1;56:1-8. doi: 10.1016/j.msec.2015.06.005. Epub 2015 Jun 12.

引用本文的文献

1
Application of Pro-angiogenic Biomaterials in Myocardial Infarction.促血管生成生物材料在心肌梗死中的应用
ACS Omega. 2024 Aug 27;9(36):37505-37529. doi: 10.1021/acsomega.4c04682. eCollection 2024 Sep 10.
2
Synthesis and Characterization of Photo-Cross-Linkable Silk Fibroin Methacryloyl Hydrogel for Biomedical Applications.用于生物医学应用的光交联甲基丙烯酰化丝素蛋白水凝胶的合成与表征
ACS Omega. 2023 Aug 15;8(34):30888-30897. doi: 10.1021/acsomega.3c01483. eCollection 2023 Aug 29.
3
Harnessing cell reprogramming for cardiac biological pacing.
利用细胞重编程实现心脏生物起搏。
J Biomed Sci. 2023 Aug 26;30(1):74. doi: 10.1186/s12929-023-00970-y.
4
Delivering on the promise of recombinant silk-inspired proteins for drug delivery.兑现基于丝蛋白的重组蛋白类药物传递系统的承诺。
Adv Drug Deliv Rev. 2023 Jan;192:114622. doi: 10.1016/j.addr.2022.114622. Epub 2022 Nov 19.
5
Gallium ions incorporated silk fibroin hydrogel with antibacterial efficacy for promoting healing of -infected wound.镓离子掺入丝素蛋白水凝胶具有抗菌功效,可促进感染伤口愈合。
Front Chem. 2022 Oct 28;10:1017548. doi: 10.3389/fchem.2022.1017548. eCollection 2022.
6
Therapeutic Acellular Scaffolds for Limiting Left Ventricular Remodelling-Current Status and Future Directions.治疗性去细胞支架限制左心室重构的研究现状与未来方向。
Int J Mol Sci. 2021 Dec 2;22(23):13054. doi: 10.3390/ijms222313054.
7
Alginate Formulations: Current Developments in the Race for Hydrogel-Based Cardiac Regeneration.藻酸盐制剂:基于水凝胶的心脏再生竞赛中的当前进展。
Front Bioeng Biotechnol. 2020 May 8;8:414. doi: 10.3389/fbioe.2020.00414. eCollection 2020.
8
Injectable Hydrogel-Based Nanocomposites for Cardiovascular Diseases.用于心血管疾病的基于水凝胶的可注射纳米复合材料
Front Bioeng Biotechnol. 2020 Mar 31;8:251. doi: 10.3389/fbioe.2020.00251. eCollection 2020.